The Brand Finance Pharma 25 report provides a comprehensive analysis of the most valuable and strongest pharma brands. The report includes expert recommendations for growing brand value, competitor benchmarking, and a cost-effective way to gain a better understanding of a brand's position against competitors. The report also includes a Brand Value Summary, Brand Strength Tracking, Cost of Capital Analysis, Royalty Rates, Customer Research Findings, Insight, Strategy, Benchmarking, Education, and Communication. The report was prepared by Brand Finance, the world's leading independent brand valuation consultancy, and was published on January 2020.
